Personal profile
External positions
University of Copenhagen
Fingerprint
Dive into the research topics where Annette Juul Vangsted is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone
Bertamini, L., Fokkema, C., Rodriguez-Otero, P., van Duin, M., Terpos, E., D'Agostino, M., van der Velden, V. H. J., van de Donk, N. W. C. J., Delforge, M., Driessen, C., Hajek, R., Einsele, H., Vangsted, A. J., Vieyra, D., Attar, R. M., Sitthi-Amorn, A., Carson, R., Schjesvold, F., Robak, P. & Beksac, M. & 6 others, , 22 Jan 2026, In: Blood. 147, 4, p. 431-442 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
5 Citations (Scopus) -
Progression-Free and Overall Survival After KRd Consolidation in FDG PET/CT Positive Patients After ASCT: A Phase II Study (CONPET)
Nørgaard, J. N., Abildgaard, N., Lysén, A., Tsykunova, G., Vangsted, A. J., João, C., Remen, N., Osnes, L., Stokke, C., Connelly, J. P., Revheim, M. E. R. & Schjesvold, F., Mar 2026, In: Clinical Lymphoma, Myeloma and Leukemia. 26, 3, p. e335-e343.e2Research output: Contribution to journal › Journal article › Research › peer-review
-
The added value of Bayesian interim analysis in randomized phase II and phase III clinical trials in hemato-oncology
Smit, A. J. T., Van der Maas, N. G., Van der Holt, B., Van Norden, Y., Van Werkhoven, E., Vangsted, A. J., Ypma, P. F., Visser-Wisselaar, H. A., Troia, R., Boccadoro, M., Löwenberg, B., Janssen, J. J. W. M., Ossenkoppele, G. J., Schjesvold, F., Sonneveld, P., Zweegman, S., Versluis, J. & Cornelissen, J. J., 1 Mar 2026, In: Haematologica. 111, 3, p. 1105-1110 6 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
-
Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group
Moore, K. L. F., Rognvaldsson, S., Szabo, A. G., Vaitekėnaitė, V., Loigom, D., Genell, A., Thorsen, J., Norgaard, J. N., Thorsteinsdottir, S., Knut-Bojanowska, D., Lysen, A., Schjesvold, F., Peceliunas, V., Kaare, A., Palk, K., Parnat, M., Sigurdsson, A., Vangsted, A. J. & Blimark, C. H., 1 Feb 2026, In: Haematologica. 111, 2, p. 693-697 5 p.Research output: Contribution to journal › Letter › peer-review
-
Adaptive designs in randomized clinical trials: reanalysis of the HOVON87/NMSG18 multiple myeloma trial
Seefat, M. R., van der Maas, N. G., Nasserinejad, K., van der Holt, B., Waage, A., Mellqvist, U. H., Vangsted, A. J., Smit, A. J. T., Smits, F., Ypma, P. F., van de Donk, N. W. C. J., Blommestein, H. M., Cornelissen, J. J., Cucchi, D. G. J., Zweegman, S. & Versluis, J., Dec 2025, In: EClinicalMedicine. 90, 103605.Research output: Contribution to journal › Journal article › Research › peer-review